+499.5%
MRNA vs VIK
+37.7%
+461.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VIK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.3% | -2.5% | -2.1% |
| 7D | +5.5% | -3.0% | +8.5% | +4.2% |
| 30D | +158.7% | -20.7% | +179.5% | +159.5% |
| 3M | +182.1% | -4.6% | +186.8% | +161.1% |
| 6M | +151.8% | +14.0% | +137.8% | +112.3% |
| YTD | +393.6% | +20.2% | +373.4% | +297.4% |
| 1Y | +499.5% | +36.0% | +463.5% | +356.0% |
| All | +499.5% | +37.7% | +461.7% | +356.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VIK.
Daily Out/Under-Performance
Portfolio return minus VIK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VIK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VIK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling